Previous studies have shown that activation of the TLR4/NF-κB signaling pathway can cause interstitial inflammation, which in turn leads to renal interstitial fibrosis, and inhibition of TLR4/NF-κB pathway activation can inhibit the progression of renal fibrosis [14, 25]. Here, NFKB1 is linked to inflammatory response.